Results 111 to 120 of about 683,577 (219)
Little is known about motivation for weight loss and barriers to weight loss among patients with idiopathic intracranial hypertension (IIH).
Lizbeth Gonzalez; Olivia Killeen; Sangeeta Khanna; Wayne Cornblath; Sui Wong; Lindsey De Lott
core
Idiopathic intracranial hypertension presenting as bilateral palpebral venous engorgement
Purpose: To report the case of a woman in her fifties whose presenting symptom of idiopathic intracranial hypertension was engorgement of the eyelid veins. Observations: Bilateral engorged palpebral veins were visible through the skin.
Samantha D. Butterfield, Rona Z. Silkiss
doaj +1 more source
Multifactorial optic disc edema
A case of intracranial hypertension secondary to renal failure is described. The patient’s symptoms of headache and optic disc swelling resolved following hemodialysis.
Bashaer M Aldhahwani +2 more
doaj +1 more source
Lumbar puncture (LP) is performed to exclude secondary causes in patients suspected of idiopathic intracranial hypertension (IIH). However, LPs may be difficult to obtain, are subject to technical issues and may have complications. The goal of this study
Amir Vosoughi; Edward Margolin; Jonathan Micieli
core
Background Currently, there is a relative lack of detailed reports regarding clinical presentation and outcome of idiopathic intracranial hypertension in Asians.
Kyung-Hee Cho +16 more
doaj +1 more source
In idiopathic intracranial hypertension (IIH), presentations with high-grade papilledema, worse visual field mean deviation (MD), and reduced visual acuity (VA) are associated with worse outcomes. Randomized data is lacking in high-risk IIH.
Jeffrey Gluckstein; Amalie Chen; Joseph Rizzo
core
The effect of Idiopathic intracranial hypertension (IIH) on reproductive health is not known. In a phenotypically similar disease, Polycystic ovary syndrome (PCOS) there is an established adverse fertility phenotype.
Ben Wakerley; Mark Thaller; Jemma Mytton; Susan Mollan; Alex Sinclair
core
The mechanism by which intracranial hypertension develops in idiopathic intracranial hypertension (IIH) remains unclear. The recently identified glymphatic system is a novel and compelling candidate mechanism.
Marc Bouffard; Yu-Ming Chang; Mahsa Alborzi; Donella Comeau; David Alsop; Narjes Jaafar; David Hackney; Jeremy Ford; Karen Buch
core
The Idiopathic Intracranial Hypertension Treatment Trial: Clinical Profile at Baseline
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as there are no properly designed and executed clinical trials to guide therapy. With this in mind, investigators of the Neuro- Ophthalmology Research Disease
Michael Wall
core

